Individualized radial waves for calcific shoulder pain · Single-group study · 2017
Does calcific shoulder pain ease with tailored radial shockwave?
In this study, people had radial shockwave once a week, tailored to them, about 7 sessions on average. Shoulder pain fell from about 7 out of 10 to under 3 at one month and under 1 at one year. Of 76 treated shoulders, 71 needed no further treatment.
Improved over time- people followed up (76 shoulders)
- 64
- sessions on average (4 to 11), one a week
- 7
- year of follow-up
- 1
Good to know: No comparison group; followed for one year. Side effects were minor: mild skin irritation or brief discomfort.
Malliaropoulos N, Thompson D, Meke M, et al. BMC Musculoskelet Disord, 2017 · Read the paper ↗
How this study worked
What happened
Shoulder pain over a year
0–10 pain scale · start, then 1, 3 and 12 months
Radial shockwave
Show the numbers
| Group | Start | 1 month | 3 months | 1 year |
|---|---|---|---|---|
| Radial shockwave | 6.7 | 2.6 | 1.7 | 0.8 |
The treatment
Radial shockwave
Radial, once a week for 7 weeks
- Sessions
- 7, one a week
- Pulses
- 2,175 per session · average; the number of sessions (4 to 11) and settings were adjusted to each person
- Strength
- 1.7bar average · 5 per second
- Numbing
- Not mentioned
- Device
- Masterpuls MP200
- Everyone also got
- Advice to avoid anti-inflammatory painkillers
Compared with: No comparison group
Settings are what each study used, not a prescription.
Who took part
67 adults (average age about 45) with calcium deposits in a shoulder tendon; 64 people (76 shoulders) completed follow-up.
hollow squares: no final score
Side effects
Five people had minor side effects: three had mild skin irritation and two had discomfort lasting up to two days. No one stopped because of side effects.
All the numbers and the full appraisal
The results, in numbers.
67 people with 79 shoulders entered; three withdrew for financial/time reasons, leaving 64 people and 76 shoulders. Mean age 44.7±8.1 years; 25 men,39 women. Acute severe calcific pain, cuff rupture, previous surgery, recent steroid injection and previous ESWT were excluded.
67 enrolled people/79 shoulders; 64 analyzed people/76 shoulders. Outcome n refers to shoulders, not people.
Shoulder pain4 reported outcomes
Shoulder pain
VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT cohort | — | 6.7 (SD 1.1) | 3.2 (SD 0.8) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Reported group means; within-group change is not a between-group treatment effect.
Analysis details and source
76 shoulders in 64 people; paired shoulders are not independent participants. Descriptive uncontrolled change.
Shoulder pain
VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT cohort | — | 6.7 (SD 1.1) | 2.6 (SD 0.9) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Reported group means; within-group change is not a between-group treatment effect.
Analysis details and source
76 shoulders in 64 people; paired shoulders are not independent participants. Descriptive uncontrolled change.
Shoulder pain
VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT cohort | — | 6.7 (SD 1.1) | 1.7 (SD 1) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Reported group means; within-group change is not a between-group treatment effect.
Analysis details and source
76 shoulders in 64 people; paired shoulders are not independent participants. Descriptive uncontrolled change.
Shoulder pain
VAS points
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Radial ESWT cohort | — | 6.7 (SD 1.1) | 0.8 (SD 1) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Reported group means; within-group change is not a between-group treatment effect.
Analysis details and source
76 shoulders in 64 people; paired shoulders are not independent participants. Descriptive uncontrolled change.
Success and recurrence1 reported outcome
Success and recurrence
Qualitative finding
VAS fell from 6.7±1.1 to 3.2±0.8,2.6±0.9,1.7±1.0 and 0.8±1.0. Figure 2 gives success 12%,51%,82%,92% at corresponding visits. Recurrence 7%, with 71/76 shoulders not requiring further treatment. Longer pretreatment duration correlated weakly with worse later pain; it did not correlate with session count (r=.080, p=.494).
Analysis details and source
Qualitative extraction preserves the source scope.
Minor adverse events1 reported outcome
Minor adverse events
Qualitative finding
Five patients had minor events: three mild skin irritation and two discomfort lasting up to two days. No adverse-event withdrawals; no long-term analgesia reported.
Analysis details and source
Qualitative extraction preserves the source scope.
How treatment was delivered
Masterpuls MP200 radial waves after ultrasound localization and coupling gel, weekly. Mean seven±1.5 sessions (reported range 4–11), pressure 1.7±0.2 bar, frequency 5±0.3 Hz, 2175±266 pulses. Settings followed tolerance; minimum three sessions planned; stop at VAS≤2 or marked improvement. NSAIDs discouraged.
Five patients had minor events: three mild skin irritation and two discomfort lasting up to two days. No adverse-event withdrawals; no long-term analgesia reported.
No control, retrospective selection, response-driven treatment duration, bilateral shoulders without clearly described clustering adjustment, no standardized function score or post-treatment calcification resolution assessment. Table 3 lists 74 shoulders at session 4 although reported minimum is 4, a source inconsistency. Storz paid publication costs; Lohrer declared research support and paid speaking.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- No control, retrospective selection, response-driven treatment duration, bilateral shoulders without clearly described clustering adjustment, no standardized function score or post-treatment calcification resolution assessment. Table 3 lists 74 shoulders at session 4 although reported minimum is 4, a source inconsistency. Storz paid publication costs; Lohrer declared research support and paid speaking.
Source-linked critical reading
uncontrolled clinical
Technical source record
Complete local PDF text read, including all article body sections, tables, figure captions, discussion, disclosures and references. The article lists no supplementary material.
Most treated shoulders improved during follow-up, but this study cannot tell how much improvement the waves caused or whether extra sessions were worthwhile.
What happened over one year after an individualized radial-wave programme for calcific shoulder pain?
Retrospective single-centre uncontrolled cohort, Greece, 2006–2013. There was no randomization or comparator and the treatment stopping rule depended on symptom improvement.
67 people with 79 shoulders entered; three withdrew for financial/time reasons, leaving 64 people and 76 shoulders. Mean age 44.7±8.1 years; 25 men,39 women. Acute severe calcific pain, cuff rupture, previous surgery, recent steroid injection and previous ESWT were excluded.
Masterpuls MP200 radial waves after ultrasound localization and coupling gel, weekly. Mean seven±1.5 sessions (reported range 4–11), pressure 1.7±0.2 bar, frequency 5±0.3 Hz, 2175±266 pulses. Settings followed tolerance; minimum three sessions planned; stop at VAS≤2 or marked improvement. NSAIDs discouraged.
No control arm; comparisons with published fixed protocols are indirect and cannot show individualized treatment superiority.
VAS 0–10 including night pain at treatment completion,1,3 and 12 months. Success generally defined as >60% pain reduction; abstract uses ≥60%. Recurrence meant additional treatment or VAS≥2 at one year. Outcomes predominantly use shoulders rather than independent people.
VAS fell from 6.7±1.1 to 3.2±0.8,2.6±0.9,1.7±1.0 and 0.8±1.0. Figure 2 gives success 12%,51%,82%,92% at corresponding visits. Recurrence 7%, with 71/76 shoulders not requiring further treatment. Longer pretreatment duration correlated weakly with worse later pain; it did not correlate with session count (r=.080, p=.494).
Five patients had minor events: three mild skin irritation and two discomfort lasting up to two days. No adverse-event withdrawals; no long-term analgesia reported.
No control, retrospective selection, response-driven treatment duration, bilateral shoulders without clearly described clustering adjustment, no standardized function score or post-treatment calcification resolution assessment. Table 3 lists 74 shoulders at session 4 although reported minimum is 4, a source inconsistency. Storz paid publication costs; Lohrer declared research support and paid speaking.
This describes feasibility and symptom trajectories in selected nonacute patients. Natural resorption, regression to the mean and care effects remain plausible explanations for improvement.
Compare individualized and fixed radial protocols with sham or usual care, account for paired shoulders, and measure function, imaging, tolerance and cost prospectively.
Read the original article.
Individualised radial extracorporeal shock wave therapy (rESWT) for symptomatic calcific shoulder tendinopathy: a retrospective clinical study
Malliaropoulos N, Thompson D, Meke M, Pyne D, Alaseirlis D, Atkinson H, Korakakis V, Lohrer H. · BMC Musculoskelet Disord · 2017
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →